Specialty Drug List
- Specialty Drug List (2018 Quarter 4) (XLS)
- Published Jan. 11
HHSC defines a specialty drug as one that meets all four of the criteria of the “Specialty Drug” rule (1 TAC Section 354.1853). The specialty drug list (SDL) identifies all drugs that meet these criteria. The SDL is published quarterly by the Texas Vendor Drug Program. More information about the criteria and when HHSC publishes the SDL is part of the Specialty Drug Drug Process (PDF).
Draft SDL for Comment
Each quarter HHSC reviews drugs that meet the rule criteria. This resulting list is published as that quarter’s draft SDL.
- Draft SDL for 2019 Quarter 1 (XLS)
- Published Feb. 22
HHSC welcomes comments from all external stakeholders regarding the draft. Stakeholders propose additions to, or removals from, the draft using the Specialty Drug Submission Spreadsheet (XLS).
A final SDL, incorporating approved public comment, is published each quarter.
February 22, 2019
Draft Specialty Drug List Available for Public Comment
January 11, 2019
2018 Q4 Specialty Drug List Now Available